HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Blish, C. A. Articles by Fink, P. J. Search for Related Content PubMed PubMed Citation Articles by Blish, C. A. Articles by Fink, P. J.

Anergic CD8⁺ T Cells Can Persist and Function In Vivo¹

Department of Immunology, University of Washington School of Medicine, Seattle, WA 98195

Using a mouse model system, we demonstrate that anergic CD8⁺ T cells can persist and retain some functional capabilities in vivo, even after the induction of tolerance. In TCR Vß5 transgenic mice, mature CD8⁺Vß5⁺ T cells transit through a CD8^lowVß5^low deletional intermediate during tolerance induction. CD8^low cells are characterized by an activated phenotype, are functionally compromised in vitro, and are slated for deletion in vivo. We now demonstrate that CD8^low cells derive from a proliferative compartment, but do not divide in vivo. CD8^low cells persist in vivo with a t_1/2 of 3–5 days, in contrast to their in vitro t_1/2 of 0.5–1 day. During this unexpectedly long in vivo life span, CD8^low cells are capable of producing IFN- in vivo despite their inability to proliferate or to kill target cells in vitro. CD8^low cells also accumulate at sites of inflammation, where they produce IFN-. Therefore, rather than withdrawing from the pool of functional CD8⁺ T cells, anergic CD8^low cells retain a potential regulatory role despite losing their capacity to proliferate. The ability of anergic cells to persist and function in vivo adds another level of complexity to the process of tolerance induction in the lymphoid periphery.

This article has been cited by other articles:

				K. A. Mitchell and B. P. Lawrence Exposure to 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) Renders Influenza Virus-Specific CD8+ T Cells Hyporesponsive to Antigen Toxicol. Sci., July 1, 2003; 74(1): 74 - 84. [Abstract] [Full Text] [PDF]

				D. Davidson, M. Bakinowski, M. L. Thomas, V. Horejsi, and A. Veillette Phosphorylation-Dependent Regulation of T-Cell Activation by PAG/Cbp, a Lipid Raft-Associated Transmembrane Adaptor Mol. Cell. Biol., March 15, 2003; 23(6): 2017 - 2028. [Abstract] [Full Text] [PDF]

				M. S. Vacchio and R. J. Hodes CD28 Costimulation Is Required for In Vivo Induction of Peripheral Tolerance in CD8 T Cells J. Exp. Med., January 6, 2003; 197(1): 19 - 26. [Abstract] [Full Text] [PDF]

				M. E. Keir, M. G. Rosenberg, J. K. Sandberg, K. A. Jordan, A. Wiznia, D. F. Nixon, C. A. Stoddart, and J. M. McCune Generation of CD3+CD8low Thymocytes in the HIV Type 1-Infected Thymus J. Immunol., September 1, 2002; 169(5): 2788 - 2796. [Abstract] [Full Text] [PDF]

				K. Steinbrink, E. Graulich, S. Kubsch, J. Knop, and A. H. Enk CD4+ and CD8+ anergic T cells induced by interleukin-10-treated human dendritic cells display antigen-specific suppressor activity Blood, April 1, 2002; 99(7): 2468 - 2476. [Abstract] [Full Text] [PDF]

				N. Bercovici, A. Heurtier, C. Vizler, N. Pardigon, C. Cambouris, P. Desreumaux, and R. Liblau Systemic Administration of Agonist Peptide Blocks the Progression of Spontaneous CD8-Mediated Autoimmune Diabetes in Transgenic Mice Without Bystander Damage J. Immunol., July 1, 2000; 165(1): 202 - 210. [Abstract] [Full Text] [PDF]

				J. M. Lumsden, J. M. Roberts, N. L. Harris, R. J. Peach, and F. Ronchese Differential Requirement for CD80 and CD80/CD86-Dependent Costimulation in the Lung Immune Response to an Influenza Virus Infection J. Immunol., January 1, 2000; 164(1): 79 - 85. [Abstract] [Full Text] [PDF]

				C. T. Nugent, D. J. Morgan, J. A. Biggs, A. Ko, I. M. Pilip, E. G. Pamer, and L. A. Sherman Characterization of CD8+ T Lymphocytes That Persist After Peripheral Tolerance to a Self Antigen Expressed in the Pancreas J. Immunol., January 1, 2000; 164(1): 191 - 200. [Abstract] [Full Text] [PDF]